Datasea partners with Linghang for brain-computer interface technology By Investing.com

Datasea Inc. has announced a strategic partnership with Nanjing Linghang Intelligent Aviation Technology Co., Ltd. to integrate its acoustic enhancement technologies into non-invasive brain-computer interface (BCI) systems and healthcare robots. This collaboration aims to address challenges in EEG signal stability and decoding accuracy, focusing on applications in rehabilitation and healthcare. The global BCI market is projected to exceed $15-20 billion by 2030, with non-invasive BCI technologies expected to be the fastest-growing segment, offering significant market potential despite Datasea's current thin gross profit margins and unprofitability.

Original reporting
Published Jan 5, 2026, 3:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jan 5, 2026, 4:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$DTSS
Bullish
medium confidence
Mentioned
$DTSS
AlphAI data visualization · based on Investing.com Australia
Decision brief

The 30-second read

$DTSSBullishMed
01

Why it matters

The collaboration could enhance Datasea's technological capabilities and market positioning, potentially leading to stock appreciation.

02

Market read

The BCI market is projected to grow significantly, with non-invasive solutions leading the segment, offering substantial growth opportunities for involved companies.

03

What to watch

Potential regulatory hurdles and competition in the BCI space could affect outcomes.

Timing: Immediate

Background

Datasea is expanding into neurotechnology through partnerships, aiming to leverage advancements in brain-computer interfaces for healthcare applications.

Company-level read

Ticker impact

$DTSSBullishMedium confidence
Context

The news involves Datasea Inc. (DTSS), highlighting a strategic partnership in brain-computer interface technology.

Expected impact

Moderate upward movement in the short to medium term.

Evidence & confidence

The collaboration aligns with growing industry trends in BCI technology, but Datasea's current profitability issues temper the impact.

Market effects

Potential uplift in the neurotechnology and healthcare robotics sectors.

Limited to regional markets with active biotech and tech sectors.

Moderate, given the global growth projection of the BCI market.

Counterpoint

The partnership's impact may be overestimated; technological challenges and Datasea's financial health could limit stock appreciation.

Key entities

  • Datasea Inc.

    A technology company focusing on IoT, AI, and neurotechnology.

  • Linghang

    Nanjing Linghang Intelligent Aviation Technology Co., Ltd., specializing in acoustic and aerospace technologies.

Related articles

$DTSSMed

Datasea Announces FDA Registration and Device Listing for NeuroVibe Acoustic BCI Biofeedback System as a Class II 510(k)

Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) said its China VIE, Shuhai Jingwei, completed FDA establishment registration and device listing for the NeuroVibe acoustic biofeedback system (NV-02, NV-03). The devices were listed as Class II 510(k)-exempt biofeedback medical devices under FDA product code HCC. Datasea said this supports U.S. commercialization planning; listing is not FDA approval.

$LMTHighAI 9/10

US clears way for $24.3 billion military aircraft sale to Saudi Arabia

The US State Department approved a $24.3 billion sale of 48 F-35 fighter jets and related equipment to Saudi Arabia, involving Lockheed Martin and Pratt & Whitney. The sale aims to support US foreign policy and regional stability, according to the department. Congress has 30 days to review the deal. The announcement follows Saudi Arabia's request for US military assistance against Yemen's Houthis, with ongoing diplomatic discussions.

$CTVAHigh

S&P downgrades Corteva rating on seed business spin-off

S&P downgraded Corteva Inc. (CTVA) to 'BBB+' from 'A-' due to its upcoming spin-off of the higher-margin seed business, reducing scale and diversification. The company's 2025 crop protection revenues were $7.5B (43% of pre-separation revenue) with EBITDA of $1.35B (34% of pre-separation EBITDA). Corteva targets $2.2B-$2.6B in cash flow from operations in 2027-2029, with priorities including M&A, share repurchases, and dividends.

$RSGMedAI 8/10

Bill Gates Just Bought 3M More Shares of This 'Boring' Stock, Which Pays Him $78M Every Quarter

Bill Gates' Cascade Investment acquired 3.06 million shares of Republic Services (RSG) between August 28 and September 11, increasing his stake to 117.05 million shares, or 38% of the company. Republic Services raised its quarterly dividend to $0.67 per share, with Gates set to receive $78.43 million from the upcoming payout. The company reported Q2 adjusted EPS of $1.85 and revenue of $4.43 billion, with full-year 2026 guidance of $7.23-$7.28 EPS on $17.20-$17.30 billion revenue.